Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06485687 · ClinicalTrials.gov registry record · NA

Low Intensity Focused Ultrasound for Binge Eating Disorder

A NA study of Binge-Eating Disorder, sponsored by Ali Rezai.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06485687 is a NA study of Binge-Eating Disorder that is active but no longer recruiting, run by Ali Rezai. The registered enrollment target is 15 participants, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06485687, a NA study of Binge-Eating Disorder, is active but no longer recruiting, sponsored by Ali Rezai.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with Binge Eating Disorder (BED)

Conditions Studied

Interventions

  • DEVICE LIFU Neuromodulation

Study Locations (1)

West Virginia

  • West Virginia University: Rockefeller Neuroscience Institute - Morgantown

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-10-31
Est. Completion 2027-12-31
Phase NA

Sponsor

Ali Rezai

4 total trials

What the Registry Record Tells You About NCT06485687

The ClinicalTrials.gov registry entry for NCT06485687 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Ali Rezai, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 1 intervention - of which LIFU Neuromodulation is the first listed.

NCT06485687 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT06485687 about?

NCT06485687 is a clinical study titled "Low Intensity Focused Ultrasound for Binge Eating Disorder". This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with Binge Eating Disorder (BED)

What is the current status of trial NCT06485687?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-10-31. Estimated completion is 2027-12-31.

What conditions does trial NCT06485687 study?

This clinical trial studies the following conditions: Binge-Eating Disorder.

What interventions are being tested in trial NCT06485687?

The interventions under investigation include: LIFU Neuromodulation (DEVICE).

Who is sponsoring clinical trial NCT06485687?

This trial is sponsored by Ali Rezai, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06485687 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Binge-Eating Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.